%0 Journal Article
%T Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
%A Bret Taback
%A Brigid Killelea
%A Cheryl A. Ewing
%A Claire L. Buchanan
%A Claudine J. Isaacs
%A Constantine Godellas
%A David A. Potter
%A Eleni A. Tousimis
%A Filipa Lynce
%A Gillian L. Hirst
%A Hanina Hibshoosh
%A Henry G. Kaplan
%A Husain A. Sattar
%A James W. Jakub
%A Jane Perlmutter
%A Jasmine M. Wong
%A Jay C. Zeck
%A Jeffrey B. Matthews
%A Jeffrey Mueller
%A Jodi M. Carter
%A Judy C. Boughey
%A Julie E. Lang
%A Kevin M. Kalinsky
%A Laura J. Esserman
%A M. Catherine Lee
%A Margaret Chen
%A Michael D. Alvarado
%A Nora T. Jaskowiak
%A Paula R. Pohlmann
%A Paulette Mhawech-Fauceglia
%A Rachael B. Lancaster
%A Rita Mukhtar
%A Rita Nanda
%A Roshni Rao
%A Smita Asare
%A Tara Sanft
%A Tina J. Hieken
%A Todd M. Tuttle
%A W. Fraser Symmans
%A and I-SPY 2 Investigators
%J Archive of "NPJ Breast Cancer".
%D 2018
%R 10.1038/s41523-018-0074-6
%X Current methods of management of axilla at the time of surgery in node positive patients who undergo NAC, as reported by participating surgeons surveyed in the I-SPY2 tria
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098077/